A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naive and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression

Joseph Diab; Rania Al-Mahdi; Sandra Gouveia-Figueira; Terkel Hansen; Einar Jensen; Rasmus Goll; Thomas Moritz; Jon Florholmen; Guro Forsdahl

doi:10.1093/ibd/izy349

A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naive and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression

Joseph Diab, Rania Al-Mahdi, Sandra Gouveia-Figueira, Terkel Hansen, Einar Jensen, Rasmus Goll, Thomas Moritz, Jon Florholmen, Guro Forsdahl

10 Citations (Scopus)

Abstract

The bioactive metabolites of omega 3 and omega 6 polyunsaturated fatty acids (?-3 and ?-6) are known as oxylipins and endocannabinoids (eCBs). These lipid metabolites are involved in prompting and resolving the inflammatory response that leads to the onset of inflammatory bowel disease (IBD). This study aims to quantify these bioactive lipids in the colonic mucosa and to evaluate the potential link to cytokine gene expression during inflammatory events in ulcerative colitis (UC).

Original language	English
Journal	Inflammatory Bowel Diseases
Volume	25
Issue number	3
Pages (from-to)	490-497
Number of pages	8
ISSN	1078-0998
DOIs	https://doi.org/10.1093/ibd/izy349
Publication status	Published - 21 Feb 2019
Externally published	Yes

Access to Document

10.1093/ibd/izy349

izy349.pdfFinal published version, 1 MBLicence: CC BY-NC

Cite this

Diab, J., Al-Mahdi, R., Gouveia-Figueira, S., Hansen, T., Jensen, E., Goll, R., Moritz, T., Florholmen, J., & Forsdahl, G. (2019). A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naive and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression. Inflammatory Bowel Diseases, 25(3), 490-497. https://doi.org/10.1093/ibd/izy349

A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naive and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression. / Diab, Joseph; Al-Mahdi, Rania; Gouveia-Figueira, Sandra et al.
In: Inflammatory Bowel Diseases, Vol. 25, No. 3, 21.02.2019, p. 490-497.

Research output: Contribution to journal › Journal article › Research › peer-review

Diab, J, Al-Mahdi, R, Gouveia-Figueira, S, Hansen, T, Jensen, E, Goll, R, Moritz, T, Florholmen, J & Forsdahl, G 2019, 'A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naive and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression', Inflammatory Bowel Diseases, vol. 25, no. 3, pp. 490-497. https://doi.org/10.1093/ibd/izy349

@article{a82dd3cd88384159af55b039a28c3201,

title = "A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naive and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression",

abstract = "The bioactive metabolites of omega 3 and omega 6 polyunsaturated fatty acids (?-3 and ?-6) are known as oxylipins and endocannabinoids (eCBs). These lipid metabolites are involved in prompting and resolving the inflammatory response that leads to the onset of inflammatory bowel disease (IBD). This study aims to quantify these bioactive lipids in the colonic mucosa and to evaluate the potential link to cytokine gene expression during inflammatory events in ulcerative colitis (UC).",

author = "Joseph Diab and Rania Al-Mahdi and Sandra Gouveia-Figueira and Terkel Hansen and Einar Jensen and Rasmus Goll and Thomas Moritz and Jon Florholmen and Guro Forsdahl",

year = "2019",

month = feb,

day = "21",

doi = "10.1093/ibd/izy349",

language = "English",

volume = "25",

pages = "490--497",

journal = "Inflammatory Bowel Diseases",

issn = "1078-0998",

publisher = "Lippincott Williams & Wilkins",

number = "3",

}

TY - JOUR

T1 - A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naive and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression

AU - Diab, Joseph

AU - Al-Mahdi, Rania

AU - Gouveia-Figueira, Sandra

AU - Hansen, Terkel

AU - Jensen, Einar

AU - Goll, Rasmus

AU - Moritz, Thomas

AU - Florholmen, Jon

AU - Forsdahl, Guro

PY - 2019/2/21

Y1 - 2019/2/21

N2 - The bioactive metabolites of omega 3 and omega 6 polyunsaturated fatty acids (?-3 and ?-6) are known as oxylipins and endocannabinoids (eCBs). These lipid metabolites are involved in prompting and resolving the inflammatory response that leads to the onset of inflammatory bowel disease (IBD). This study aims to quantify these bioactive lipids in the colonic mucosa and to evaluate the potential link to cytokine gene expression during inflammatory events in ulcerative colitis (UC).

AB - The bioactive metabolites of omega 3 and omega 6 polyunsaturated fatty acids (?-3 and ?-6) are known as oxylipins and endocannabinoids (eCBs). These lipid metabolites are involved in prompting and resolving the inflammatory response that leads to the onset of inflammatory bowel disease (IBD). This study aims to quantify these bioactive lipids in the colonic mucosa and to evaluate the potential link to cytokine gene expression during inflammatory events in ulcerative colitis (UC).

U2 - 10.1093/ibd/izy349

DO - 10.1093/ibd/izy349

M3 - Journal article

C2 - 30476077

SN - 1078-0998

VL - 25

SP - 490

EP - 497

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

IS - 3

ER -

A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naive and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression

Abstract

Access to Document

Fingerprint

Cite this